Multiple endocrine neoplasia type 2B
Active Research Protocols
- 07-C-0189 – Phase I/II Trial of Vandetanib (ZD6474, ZACTIMA) in Children and Adolescents with Hereditary Medullary Thyroid Carcinoma
- 12-C-0178 – Longitudinal Assessment and Natural History Study of Children and Young Adults with Medullary Thyroid Carcinoma
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014